Racemates versus enantiomers in drug development: dogmatism or pragmatism?
Testa
B
B
Institut de Chimie thérapeutique, Ecole de Pharmacie, Université de Lausanne, CH-1005, Switzerland.
Trager
W F
WF
D015195:Drug Design; D004355:Drug Stability; D010599:Pharmacokinetics; D013237:Stereoisomerism